Status and phase
Conditions
Treatments
About
melatonin loaded in injectible platelet rich fibrin in treatment of periodontitis
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Diagnosed with stage II periodontitis based on AAP/EFP 2018 classification
• Minimum of two non-adjacent periodontal pockets <5 mm in different quadrants
• Systemically healthy individuals willing to participate and comply with follow-up visits
• Radiographic bone loss (ranged from is 10-20% mostly horizontal
Exclusion criteria
History of systemic diseases affecting periodontium (e.g., diabetes, osteoporosis)
• Use of antibiotics, anti-inflammatories, or antioxidant supplements in the past 3 months
• Smoking or tobacco use
• Pregnancy or lactation
• Allergy to melatonin or related compounds
-
Primary purpose
Allocation
Interventional model
Masking
60 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal